Literature DB >> 7024428

C3b receptor in normal human skin.

H N Thyresson, F C McDuffie, A L Schroeter.   

Abstract

Receptors for C3b in normal skin were studied. C3b was produced by treating normal human serum with cobra venom factor and by partial digestion of purified C3 with trypsin. Cryostat sections of normal human skin were incubated with C3b, followed by a direct immunofluorescent technique using monospecific goat antihuman C3. The histologic localization of C3b fluorescence was ascertained by fixing cryostat sections with glutaraldehyde and staining with hematoxylin and eosin. The following structures showed staining with anti-C3: (1) endothelial cells in capillaries, larger vessels, and arteries, (2) smooth muscle in arrector pilori muscles and artery walls, and (3) myoepithelial cells in the secretory portion of sweat glands. C3b did not bind to the intercellular substance nor to the basement membrane zone in normal human skin. Normal human sera treated with EDTA, EGTA, and heat (56 degrees C for 30 min) were negative, as was purified C3 by itself, thus indicating that native C3 did not bind to these receptors. Specificity for C3/C3b was shown by blocking with both unconjugated rabbit antihuman C3 and purified C3. The endothelial C3b receptor may have an important role in the localization of immune complexes in cutaneous vasculitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7024428     DOI: 10.1111/1523-1747.ep12493255

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Expression and localization of proteins of the complement system in human skin.

Authors:  N Dovezenski; R Billetta; I Gigli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  The N-terminal amino acid sequence of the psoriasis-associated antigen, pso p27.

Authors:  O J Iversen; H Lysvand; K Bergh; J Eriksen; S Elsayed
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 3.  Factors influencing immune complex localisation.

Authors:  L Schrieber; R Penny
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.